FarmPharma AB, which is subsidiary to Double Bond Pharmaceutical AB, has today started the project at Testa Center as a part of cooperation agreement with GE Healthcare in Uppsala. As previously announced, FarmPharma has been granted financial means for this project within the framework of the “BioProcess Innovation Center” from Vinnova. The work is expected to last for one week in July and two weeks in August. The purpose of the project is to test the manufacturing procedure of InterferOX components on a larger scale to facilitate the successful transition to industrial GMP manufacturing of the product.
“We have been preparing for this project intensively during the past months and are eager to start the work. We were looking forward to this for some time and are very happy that our cooperation is now real”, – comments Iulia Karlsson, CEO of FarmPharma. – Ge Healthcare is very experienced in our industry and has a lot of expertise relevant to our project, which will both ensure the quality and speed up our product development.”
More about Testa Center
More about InterferOX